fluorescein-5-isothiocyanate has been researched along with butaprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drecoll, E; Guerra, T; Kharlamb, A; Krauss, AH; Lütjen-Drecoll, E; Nieves, A; Nilsson, SF; Toris, CB; Woodward, DF | 1 |
| Kharlamb, AB; Krauss, AH; Nieves, AL; Nilsson, SF; Toris, CB; Woodward, DF | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and butaprost
| Article | Year |
|---|---|
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
Topics: Administration, Topical; Alprostadil; Animals; Aqueous Humor; Ciliary Body; Dextrans; Disease Models, Animal; Fluorescein-5-isothiocyanate; Fluorophotometry; Intraocular Pressure; Macaca fascicularis; Muscle, Smooth; Ocular Hypertension; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Sclera; Trabecular Meshwork; Uvea | 2006 |
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
Topics: Alprostadil; Animals; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Atropine; Ciliary Body; Dextrans; Dinoprostone; Disease Models, Animal; Female; Fluorescein-5-isothiocyanate; Fluorophotometry; Humans; Intraocular Pressure; Isometric Contraction; Macaca fascicularis; Muscle, Smooth; Ocular Hypotension; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Sclera; Tonometry, Ocular; Transfection; Uvea | 2009 |